Assessment of leukemia inhibitory factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization.
OBJECTIVE
To assess intrauterine levels of leukemia inhibitory factor (LIF) by uterine flushing at the time of egg retrieval and to confirm that the procedure has no detrimental effect on pregnancy rates.


METHODS
Prospective study.


METHODS
Assisted reproductive unit of a university hospital.


METHODS
Uterine flushing was performed in 148 IVF patients. The first 100 patients were compared with a matched control group.


METHODS
Uterine flushing at the time of egg retrieval.


METHODS
IVP-ET results, pregnancy rates, and intrauterine LIF levels.


RESULTS
Pregnancy rates were not different in the group of patients with (27%) or without uterine flushing (28%). Leukemia inhibitory factor was detected in 60 patients (46%). Pregnancy rates did not differ between patients' detectable LIF and those in whom LIF was undetectable. Mean levels of LIF were 30.1 +/- 49.3 pg/mL and 28.6 +/- 51.2 pg/mL in pregnant and nonpregnant patients respectively.


CONCLUSIONS
The flushing procedure at the time of egg retrieval did not adversely affect pregnancy rates. Leukemia inhibitory factor was detected in 46% of patients at the time of egg retrieval, but no correlation were observed with better pregnancy rates in patients with detectable LIF. Mean LIF levels did not differ in pregnant and nonpregnant women. Access to endoluminal secretions of the endometrium during IVF-ET may represent a new research in human implantation.
Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, Clamart, France. francois.olivennes@cch.ap-hop-paris.fr
François
F
Olivennes
Nathalie
N
Lédée-Bataille
Marise
M
Samama
Jacques
J
Kadoch
Jean-Luc
JL
Taupin
Sylvie
S
Dubanchet
Gérard
G
Chaouat
René
R
Frydman
D000328:Adult; D016022:Case-Control Studies; D010064:Embryo Implantation / Q000502:physiology*; D004624:Embryo Transfer; D004717:Endometrium / Q000378:metabolism / Q000502:physiology; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006131:Growth Inhibitors / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000378:metabolism*; D008297:Male; D009865:Oocytes / Q000378:metabolism / Q000502:physiology*; D010062:Ovulation Induction / Q000379:methods; D011247:Pregnancy; D018873:Pregnancy Rate; D011446:Prospective Studies; D007507:Therapeutic Irrigation / Q000009:adverse effects; D014599:Uterus / Q000378:metabolism / Q000502:physiology*
D006131:Growth Inhibitors; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines